Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group (2010). “Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis”. Critical care medicine38 (1): 72–83. doi:10.1097/CCM.0b013e3181b07b78. PMID19661804.
Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group (2010). “Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis”. Critical care medicine38 (1): 72–83. doi:10.1097/CCM.0b013e3181b07b78. PMID19661804.